ANTI-CD20 ANTIBODIES AND THERAPEUTIC USES THEREOF
Provided herein are novel anti-CD20 antibodies that exhibit several advantageous properties as compared to rituximab.
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English French German |
Published |
30.08.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Provided herein are novel anti-CD20 antibodies that exhibit several advantageous properties as compared to rituximab. |
---|---|
Bibliography: | Application Number: EP20210807446 |